Syphilis Diagnosis and Treatment
Clinical Significance and Diagnosis
- A titer of 1:64 is highly specific for true syphilis infection, as false-positive results at titers ≥1:8 are extremely rare, and titers ≥1:32 are considered high-titer results that strongly indicate active disease 1, 2.
- Patients with high nontreponemal titers (≥1:32) should be considered as having early syphilis for purposes of partner notification and presumptive treatment of exposed contacts 3.
Immediate Clinical Actions Required
- Obtain a confirmatory treponemal test (TP-PA, FTA-ABS, or treponemal EIA) if not already performed, as both nontreponemal and treponemal tests must be reactive for syphilis diagnosis 1, 2.
- Perform a thorough physical examination looking specifically for signs of primary or secondary syphilis 1.
- Determine the stage of infection through clinical history, symptoms, and timing of exposure to guide appropriate treatment duration 3, 1.
Treatment Recommendations
- The Centers for Disease Control and Prevention recommends benzathine penicillin G 2.4 million units IM as a single dose for primary or secondary syphilis 3, 1.
- For early latent syphilis, benzathine penicillin G 2.4 million units IM as a single dose is recommended 4, 1.
- For late latent or unknown duration syphilis, benzathine penicillin G 2.4 million units IM once weekly for 3 consecutive weeks is recommended 4, 5, 1.
Expected Treatment Response and Monitoring
- Monitor RPR titers at 3, 6, 9, 12, and 24 months after treatment for early syphilis 1.
- A fourfold decline in titer within 6-12 months indicates adequate treatment response 6, 4, 1.
Partner Management
- All sexual contacts within 90 days before diagnosis should be treated presumptively, even if seronegative, as they may be in the incubation period 3.